Short-term Adverse Events After the Third Dose of the BNT162b2 mRNA COVID-19 Vaccine in Adults 60 Years or Older

被引:12
|
作者
Auster, Oren [1 ]
Finkel, Uriah [1 ]
Dagan, Noa [1 ,2 ,3 ,4 ,5 ]
Barda, Noam [1 ,2 ,3 ,4 ,5 ]
Laufer, Alon [6 ,7 ]
Balicer, Ran D. [1 ,6 ,8 ]
Ben-Shachar, Shay [1 ,4 ,5 ,9 ]
机构
[1] Clalit Res Inst, Innovat Div, Clalit Hlth Serv, 101 Arlozorov St, IL-6209804 Tel Aviv, Israel
[2] Ben Gurion Univ Negev, Software & Informat Syst Engn, Beer Sheva, Israel
[3] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA
[4] Harvard Med Sch, Ivan & Francesca Berkowitz Family Living Lab Coll, Boston, MA 02115 USA
[5] Clalit Res Inst, Boston, MA USA
[6] Clalit Hlth Serv, Tel Aviv, Israel
[7] Univ Haifa, Sch Publ Hlth, Haifa, Israel
[8] Ben Gurion Univ Negev, Sch Publ Hlth, Beer Sheva, Israel
[9] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
关键词
D O I
10.1001/jamanetworkopen.2022.7657
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Rhabdomyolysis after BNT162b2 mRNA Covid-19 vaccine in an adolescent male
    Sutcu, Murat
    Gul, Doruk
    Atik, Fatih
    Kara, Manolya
    MALAWI MEDICAL JOURNAL, 2022, 34 (02) : 154 - 156
  • [42] DIAPHRAGMATIC PARALYSIS FOLLOWING SECOND DOSE OF THE BNT162B2 MRNA COVID-19 VACCINE
    Prudenti, John A.
    Mann, Jack M.
    CHEST, 2022, 162 (04) : 1597A - 1597A
  • [43] Worsening of the vitiligo following the second dose of the BNT162B2 mRNA COVID-19 vaccine
    Okan, Gokhan
    Vural, Pervin
    DERMATOLOGIC THERAPY, 2022, 35 (03)
  • [44] Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors
    Waissengrin, Barliz
    Agbarya, Abed
    Safadi, Esraa
    Padova, Hagit
    Wol, Ido
    LANCET ONCOLOGY, 2021, 22 (05): : 581 - 583
  • [45] Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in children under 5 years
    Strumann, Christoph
    Ranzani, Otavio
    Moor, Jeanne
    Berner, Reinhard
    Toepfner, Nicole
    Chao, Cho-Ming
    Moor, Matthias B.
    JOURNAL OF CLINICAL INVESTIGATION, 2023, 133 (21):
  • [46] BNT162b2 Covid-19 Vaccine in Adolescents
    Lin, Chen-Hsing
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (14): : 1342 - 1343
  • [47] Secondary Syphilis Unmasked by BNT162b2 mRNA COVID-19 Vaccine
    Potasman, Israel
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2022, 24 (05): : 337 - 338
  • [48] Adverse reactions to BNT162b2 mRNA COVID-19 vaccine in medical staff with a history of allergy
    Inoue, Sumito
    Igarashi, Akira
    Morikane, Keita
    Hachiya, Osamu
    Watanabe, Masafumi
    Kakehata, Seiji
    Sato, Shinya
    Ueno, Yoshiyuki
    RESPIRATORY INVESTIGATION, 2022, 60 (02) : 248 - 255
  • [49] Cardiovascular Manifestation of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents
    Mansanguan, Suyanee
    Charunwatthana, Prakaykaew
    Piyaphanee, Watcharapong
    Dechkhajorn, Wilanee
    Poolcharoen, Akkapon
    Mansanguan, Chayasin
    TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2022, 7 (08)
  • [50] Unusual lymphadenopathies secondary to the BNT162b2 mRNA Covid-19 vaccine
    Manuel Felices-Farias, Jose
    Francisco Martinez-Martinez, Juan
    Guzman-Aroca, Florentina
    MEDICINA CLINICA, 2022, 158 (07): : 343 - 344